Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

Who takes care of caregivers? ACCESS aims to answer that with Exhale: a program offering resources, community support and expert guidance to ease the challenges of senior caregiving. The program's ...